Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

First epinephrine nasal spray clears key FDA hurdle, promising needle-free alternative

Por: CBS News Politics May 12, 2023

thumbnail

A committee of the Food and Drug Administration's outside advisers voted Thursday in favor of an epinephrine nasal spray product, clearing a key hurdle for what could soon be the first needle-free option for treating severe allergic reactions.The majority backing the spray for both adults and kids followed a daylong of the agency's Pulmonary-Allergy Drugs Advisory Committee, picking apart an application from ARS Pharmaceuticals for... + full article



Similar News

FDA advisers clear hurdle for epinephrine nasal spray

The Hill USA Health May 15, 2023

thumbnailA Food and Drug Administration (FDA) advisory panel an epinephrine nasal spray, clearing a hurdle for the product designed to help those with severe, potentially life-threatening allergic reactions.  The panel, the Pulmonary-Allergy Drugs Advisory Committee, voted on Thursday... + más

First epinephrine nasal spray clears key FDA hurdle, promising needle-free alternative | CBS News

In-flight emergencies raise concerns about airlines' medical kit requirements | CBS News


Doctor calling for FAA, Southwest changes after midair scare

ABC News USA Life May 06, 2023

thumbnailFollowing a mid-air scare, a doctor is calling for the Federal Aviation Administration to make policy changes and for Southwest Airlines to stock lifesaving epinephrine auto-injectors aboard passenger planes.Lindsey Ulin, an internal medicine resident physician at Brigham and... + más

SpaceX could be fined $175K for failure to properly report launch data to FAA | Ars Technica

FAA says mobile home residents must move or Vero Beach will lose airport funding | WPTV


FDA approves over-the-counter Narcan for opioid OD reversal

New York Post USA Life March 29, 2023

thumbnailOn Wednesday, the Food and Drug Administration approved the first over-the-counter nasal spray that rapidly reverses the effects of an opioid overdose. Narcan, a 4-milligram naloxone hydrochloride nasal spray, will not require a prescription and will be available in... + más

FDA approves first over-the-counter Narcan | Politico

F.D.A. Approves Narcan for Over-the-Counter Sales | The New York Times


Spectrum Recalls Epinephrine Bulk API Powder

RTTNews USA Health January 11, 2023

thumbnailSpectrum Laboratory Products, Inc. is recalling three lots of Epinephrine (L-Adrenaline) USP citing discoloration of the product, the U.S. Food and Drug Administration said.Epinephrine is a bulk active pharmaceutical ingredient or API used to manufacture or compound prescription... + más

In-flight emergencies raise concerns about airlines' medical kit requirements | CBS News

Council Post: How To Deliver Value Through Your API Strategy In 2023 And Beyond | Forbes


In-flight emergencies raise concerns about airlines' medical kit requirements

CBS News USA Nation December 10, 2022

thumbnailMatt Luptak was flying with his 11-year-old daughter Sophia when her eyes started swelling and her airway began to close. I knew an EpiPen was what I needed, Luptak said. The flight attendant tells me, 'We don't have those.' Commercial airlines by the Federal... + más

The Movie Scene That Will Make You Break Down and Ugly Cry | The Daily Beast

Warning: Airlines are keeping flight delay data hidden as holidays loom | Newsweek


Without a nasal vaccine, the U.S. edge in fighting Covid is on the line

Politico USA Health October 15, 2022

thumbnailBiden administration officials are raising concerns that the slow pace of developing a nasal vaccine for Covid-19 in the U.S. could pose a security risk as China, Iran and Russia approve their own vaccines taken through the nose or mouth. Though nasal and oral vaccines are being... + más

Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab | Ars Technica

Nasal COVID vaccine fails to offer desired protection in testing | The Hill


Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab

Ars Technica USA Science October 12, 2022

thumbnailNavigate Filter by topic Settings Front page layout Site theme Comment activity Sign up or login to join the discussions! Sign up to comment and more - Oct 12, 2022 5:17 pm UTC / A man receives an H1N1 nasal flu spray vaccine at an urgent care center on October 16, 2009, in Lake... + más

Nasal COVID vaccine fails to offer desired protection in testing | The Hill

Fintech Company Greenphire Wants To Make Clinical Trials More Representative Of Every Person, From All Backgrounds And Abilities | Forbes



About iurex | Privacy Policy | Disclaimer |